Protein Engineering News and Research

RSS
RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

Scientists build tiny "molecular drill bits" that kill bacteria by bursting through their protective cell walls

Scientists build tiny "molecular drill bits" that kill bacteria by bursting through their protective cell walls

Novimmune closes Series B financing for CHF 60 million

Novimmune closes Series B financing for CHF 60 million

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

University of Liège joins IMI programme to develop new antibiotics against Gram-negative pathogens

Llama-derived antibodies open door to development of new treatments for C. difficile infections

Llama-derived antibodies open door to development of new treatments for C. difficile infections

New technology efficiently transfers investigational antibodies from blood via blood-brain barrier

New technology efficiently transfers investigational antibodies from blood via blood-brain barrier

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Study raises hopes for new drugs to treat brain disorders associated with neurotransmitter imbalance

Study quantifies photoactivation efficiency of fluorescent proteins

Study quantifies photoactivation efficiency of fluorescent proteins

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

MedImmune, Johns Hopkins University enter into $6.5M research collaboration

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

EU-funded project develops new type of vaccine to tackle HIV virus infection

EU-funded project develops new type of vaccine to tackle HIV virus infection

Nano-material within cells could lead to engineered bio-composites for drug delivery, artificial tissue

Nano-material within cells could lead to engineered bio-composites for drug delivery, artificial tissue

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Researchers receive NIH grant to study key proteins linked to cancer and diabetes

Researchers receive NIH grant to study key proteins linked to cancer and diabetes

Researchers show how Src kinase influences inner workings of cells

Researchers show how Src kinase influences inner workings of cells

Researchers develop promising drug candidate to treat psoriasis

Researchers develop promising drug candidate to treat psoriasis

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

NRC, AvidBiologics partner to develop three novel ADCs for treatment of cancer

NRC, AvidBiologics partner to develop three novel ADCs for treatment of cancer

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke